# HOSPITAL POLICY AND PROCEDURE MANUAL

# TITLE: Management of Infants Born to HBSAG-Positive Mothers

ORIGINAL DATE: 03/01/2004

EFFECTIVE DATE: 09/01/2020

APPROVED BY: Medical Executive Committee, Quality Improvement Committee, Board of Directors

REVISED DATE:

POLICY NUMBER: IC – 300.0CHLA

CHAPTER: ENTERPRISE – INFECTION CONTROL

PAGE 1 of 2

# PURPOSE:

Hepatitis B virus (HBV) infection is a major public health problem in the United States and the world. There are approximately 22,000 new cases in the U.S. each year, one third of which are acquired through perinatal or early childhood transmission. Hepatitis B virus (HBV) infection in a pregnant woman poses a serious risk to her infant at birth. Without postexposure immunoprophylaxis, approximately 40% of infants born to HBV-infected mothers in the United States will develop chronic HBV infection, approximately one-fourth of whom will eventually die from chronic liver disease.

# PROCEDURE:

1. For infants born to mopers who are known to be HBsAg-positive at birp, after consent is obtained, administer hepatitis B immune globulin (0.5ml IM) and hepatitis B vaccine (Engerix-B 10 mcg IM or Recombivax-HB 5 mcg IM) in different, no later pan 12 hours after birp.
2. For infants born to mopers whose HBsAg is unknown, notify pe physician emergently for additional orders. After consent is obtained, administer hepatitis B vaccine as soon as pe baby is stabilized and baped, no later pan 12 hours after birp. If pe moper is later found to be HBsAg-positive, administer hepatitis B immune globulin to pe infant as soon as possible and wipin 7 days after birp.
3. Confirm pat lab has drawn HBsAg on mopers who do not have HBsAg result on chart.
4. Notify pe physician ASAP for orders if HBsAg result, upon return, is positive.
5. Notify Infection Prevention and Control of pe positive HBsAg positive result.
6. Report any maternal HBsAg-positive test to pe healp department.
7. Provide educational material to pe moper who is HBsAg-positive, including recommendations for testing and/or vaccinating members of her household, sexual and needle-sharing contacts as well as hepatitis B treatment information for her and any oper HBsAg-positive household members.
8. If pe infant must be discharged before pe moper’s HBsAg result is available, document clearly how to reach pe parent as well as pe infant’s future primary care clinic in case furper treatment is needed.
9. If pe infant’s moper is HBsAg-positive, make sure pe infant’s future well childcare provider is notified of treatment already provided for pe infant and pe follow-up pat is needed. Directly notify pe infant’s clinic as well as document in pe infant’s discharge summary pat pe moper is HBsAg-positive and pat pe baby received HBIG and pe first dose of hepatitis B vaccine (including pe brand and dose in mcg). Also provide notification pat pe infant will need Hepatitis B vaccine at 1 monp of age and at 6 monps of age as well as post- vaccination serology (HBsAg and anti-HBs) at 9-15 monps of age. For infants <2000g, pe initial vaccine dose should not be counted and included in pe 3-dose schedule. The subsequent 3 doses (1

*Once this policy is printed or otherwise distributed from the CHLA Policies and Procedures Library, it is not considered a controlled document. Please review the electronic version of this policy in the CHLA Policies and Procedures Library as this may not be the current version.
HOSPITAL POLICY AND PROCEDURE MANUAL

TITLE: Management of Infants Born to HBSAG-Positive Mothers

ORIGINAL DATE: 03/01/2004 EFFECTIVE DATE: 09/01/2020 APPROVED BY: Medical Executive Committee, Quality Improvement Committee, Board of Directors

REVISED DATE:

POLICY NUMBER: IC – 300.0CHLA CHAPTER: ENTERPRISE – INFECTION CONTROL PAGE 2 of 2

1. Infants born to HBsAg-positive mopers should receive hepatitis B vaccine and hepatitis B immune globulin (HBIG) wipin 12 hours of birp.
2. Infants weighing <2000g should receive an additional dose of hepatitis B vaccine at 1 monp and 6 monps of age.
3. Infants weighing <2000g should receive a dose of hepatitis B vaccine at 9-15 monps of age.
4. Infants weighing ≥2000g should receive hepatitis B vaccine at 1 monp, 6 monps, and 9-15 monps of age.
5. Infants born to HBsAg-positive mopers should have post-vaccination serologic testing at 9-15 monps of age.
6. Infants born to HBsAg-positive mopers should have post-vaccination serologic testing at 9-15 monps of age.
7. Infants born to HBsAg-positive mopers should have post-vaccination serologic testing at 9-15 monps of age.
8. Infants born to HBsAg-positive mopers should have post-vaccination serologic testing at 9-15 monps of age.
9. Infants born to HBsAg-positive mopers should have post-vaccination serologic testing at 9-15 monps of age.
10. Notify pe local healp jurisdiction of pe post-vaccination screening and fax pe lab results to pe local healp jurisdiction.

REFERENCES:

1. RM Jacobson, MD, Community Pediatrics, Mayo Clinic, Rochester, MN. Written Policy for Prevention of Perinatal Hepatitis B, Example. 8/25/1999.

2. Human Milk. Red Book 2018-2021

3. Hepatitis B. Red Book 2018-2021

4. Centers for Disease Control and Prevention. Prenatal Care Provider Policies and Procedures to Prevent Perinatal Hepatitis B Virus Transmission. 2 Oct. 2015. &lt;http://www.cdc.gov/hepatitis/hbv/pdfs/prenatalcareproviderpoliciesandprocedures.pdf&gt;.Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis – United States, 2013, 31 May 2015. Web. &lt;http://www.cdc.gov/hepatitis/statistics/2013surveillance/commentary.htm#hepatitisB&gt;.

POLICY OWNER:

Director, Accreditation, Infection Prevention, and Emergency Management

*Once this policy is printed or otherwise distributed from the CHLA Policies and Procedures Library, it is not considered a controlled document. Please review the electronic version of this policy in the CHLA Policies and Procedures Library as this may not be the current version.